OMNIQ Reports Third Quarter Financial Results
SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- OMNIQ Corp (OTCMTS:…
Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
November 14, 2025 16:05 ET | Source: Terns Pharmaceuticals, Inc. FOSTER CITY,…
TOMI Environmental Solutions, Inc. Reports Q3 2025 Financial Results and Outlines Growth Initiatives
FREDERICK, Md., Nov. 14, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.…
Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results
– Company reports $14.3 million in revenue in Q3’25, consisting of $3.6…
Applied Digital Announces Pricing of $2.35 Billion of Senior Secured Notes
November 13, 2025 19:05 ET | Source: Applied Digital Corporation DALLAS, Nov.…
CORRECTION – POET Technologies Reports Third Quarter 2025 Financial Results
November 13, 2025 18:16 ET | Source: POET Technologies Inc. TORONTO, Nov.…
Data Storage Corporation Postpones 2025 Third Quarter Business Update Conference Call
November 13, 2025 17:50 ET | Source: Data Storage Corp. MELVILLE, N.Y.,…
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX)…
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
INSIDE INFORMATIONREGULATED INFORMATION Correction and ReplacementNyxoah Secures Financing Commitments of up to…
LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in the United Kingdom
November 13, 2025 18:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE,…
